Navigation Links
Dr. Paul Korner Promoted to Senior Vice President of Ferring International PharmaScience Center U.S.
Date:3/17/2009

PARSIPPANY, N.J., March 17 /PRNewswire/ -- Ferring Pharmaceuticals Inc., a specialty pharmaceutical company, announces the promotion of Paul Korner, M.D., M.B.A. to Senior Vice President of the Ferring International PharmaScience Center U.S. (FIPCUS), the drug development subsidiary for Ferring Pharmaceuticals Inc. Dr. Korner was formerly Vice President, Medical Affairs for Ferring's Infertility, Orthopaedics, Urology, and Gastroenterology therapeutic areas, as well as Product Safety. In his new role, Dr. Korner will be responsible for the clinical management of U.S. drug development.

"Dr. Korner has made tremendous strides in his first six months with Ferring, and is exceptionally well qualified to lead the clinical programs at our PharmaScience Center," said Wayne Anderson, President and CEO of Ferring Pharmaceuticals Inc., and Chairman of FIPCUS. "He will oversee the drug development of our rich pipeline of products as we continue our quest to achieve rapid new drug approvals by identifying, improving and commercializing late-stage or marketed products in our clinical specialty areas."

Dr. Korner joined Ferring in 2008 with a broad range of experience in medical affairs, clinical development, management and business development. During his first six months at Ferring, he restructured the Medical Affairs and Product Safety departments, created a Medical Information department, and was instrumental in the pre-launch activities for newly approved degarelix for injection.

Prior to joining the company, Dr. Korner was Vice President of Medical Affairs, Women's Healthcare at Bayer HealthCare Pharmaceuticals, where his group supported the U.S. Women's Healthcare business unit, and managed medical experts supporting Phase II and III development projects. He has also served as Executive Director of Medical Affairs, Female Healthcare at Berlex Laboratories, Inc., and Senior Director of Clinical Research and De
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
2. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
3. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
6. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
7. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
8. Schering-Plough Announces Pricing of Senior Notes Offering
9. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
10. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
11. Solazyme Announces New Senior Vice President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building ... 25 organizations will continue their work to increase awareness ... in daily life with the aid of SPIE ... 10 countries, are the first of two groups of ... the international society for optics and photonics , in ...
(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... , , SAN MARINO, Calif., ... scientist at biotechnology company Viral Genetics (Pink Sheets: VRAL), will ... Newell,s presentation entitled: "The Impact of Custom Peptides on Chronic ... The conference is being held at The Loews Santa Monica ...
... , DAEJEON, South Korea, Sept. 16 ... fully-human monoclonal antibodies for the treatment of cancer and inflammatory ... a Series A financing. OrbiMed,s Caduceus Asia Partners and ... from an international syndicate including Green Cross, Tong Yang and ...
... BEIJING, Sept. 16 /PRNewswire-Asia/ -- ... has announced it will broaden inclusion,criteria for its ... use,stem cells derived from peripheral blood to treat ... foot ulcers involves intensive,wound management, risk reduction and ...
Cached Biology Technology:Viral Genetics' Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference 2PharmAbcine Closes USD $6 Million Series A Financing 2PharmAbcine Closes USD $6 Million Series A Financing 3PharmAbcine Closes USD $6 Million Series A Financing 4Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 2Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 3Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 4
(Date:5/20/2013)... a compound abundant in the Mediterranean diet takes away ... altering a very specific step in gene regulation, this ... die as scheduled. , One way that cancer cells ... them to die on a regular cycle that is ... by Ohio State University researchers, found that a compound ...
(Date:5/20/2013)... Geology articles posted online ahead of ... wide swath of geoscience subdisciplines, including minerals exploration, ... Locations studied include Siberia; the Sumatran subduction margin; ... Ukraine; Mars; and the Southeastern U.S. Atlantic Margin. ... and plate tectonics;, 2. The clear fingerprint of ...
(Date:5/18/2013)... The AGA Research Foundation is honored to announce ... in Digestive Cancer, which will support Andrew D. Rhim, ... University of Pennsylvania, Philadelphia, as he furthers his research ... and cancer progression. , "The AGA Research Foundation is ... distinguished clinicians and AGA Legacy Society members," said Nicholas ...
Breaking Biology News(10 mins):The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... of bees and other pollinators is not, at this ... of an international study published in the latest edition ... , Co-author, CSIRO Entomology,s Dr Saul Cunningham, says ... for pollinators is still growing and some highly pollinator-dependant ...
... A team of researchers led by North Carolina State University ... devices and a host of other revolutionary medical implants. The ... material can be used to create new devices that can ... sensors for diabetics and artificial hemo-dialysis membranes that can scrub ...
... 156th Acoustical Society of America (ASA) meeting convenes next ... Spa in Miami. Reporters are invited to visit the ... On this site are posted news releases and ... 660 talks and posters. They relate to a cross-section ...
Cached Biology News:Pollinator decline not reducing crop yields just yet 2NC State finds new nanomaterial could be breakthrough for implantable medical devices 2The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 2The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 3The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 4
Ready-to-use solution....
ready-to-use solution...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Clone/PAD: ZMD.420. Immunogen: ... Specificity: Specific for the ... Reactivity: Human (positive control: ... Based on sequence homology reactivity ...
Biology Products: